BSA RTA is a research-designated synthetic triple agonist peptide (commonly known as Retatrutide) studied in metabolic and endocrine research. It is designed to interact with multiple hormone receptors, specifically GLP-1, GIP, and glucagon receptors, making it relevant for investigating multi-pathway metabolic regulation in controlled laboratory settings.

Chemical & Structural Properties

• Compound designation: BSA RTA
• Reference compound: Retatrutide
• Peptide class: Triple receptor agonist
• Target receptors: GLP-1, GIP, glucagon
• Form: Lyophilized powder
• Purity: ≥99% (research-grade)
• Engineered for enhanced stability and receptor interaction

Biological Role (Research Context)

BSA RTA is investigated in experimental systems for:

• Simultaneous activation of multiple metabolic hormone pathways
• Regulation of energy balance and metabolic signaling
• Glucose metabolism and insulin-related pathway studies
• Hormonal pathway interaction and receptor synergy
• Cellular metabolic response mechanisms

Mechanistic Areas of Study

Research commonly focuses on:

• Multi-receptor signaling integration
• Metabolic and endocrine pathway modulation (in vitro / animal models)
• Energy expenditure and substrate utilization
• Receptor binding and signaling dynamics
• Peptide stability and pharmacokinetics

Laboratory & Research Applications

Used in controlled research environments for:

• Metabolic and endocrine system studies
• Peptide–receptor interaction assays
• Cell culture and in vivo experimental models
• Biochemical and molecular pathway analysis
• Pharmacological research and development

Handling & Storage (Research Settings)

• Store at −20°C or lower
• Protect from light, heat, and moisture
• Reconstitute using sterile laboratory-grade solvents or buffers
• Avoid repeated freeze–thaw cycles
• Follow aseptic laboratory procedures

Important Notice

This product is intended strictly for research purposes only.
It is not for human consumption, clinical use, or therapeutic application.